companies
>
E
> Eli Lilly
Eli Lilly
Drugmaker Eli Lilly withdraws drug application to treat chronic pain
29 November 2008
Eli Lily's suspension of arthritis drug development expected to hit Glenmark's pipeline
24 October 2008
Eli Lilly to acquire ImClone for $6.5 billion
06 October 2008
Jubilant in R&D, clinical trial joint venture with Eli Lilly
04 October 2008
Mystery buyer Eli Lilly reported to outbid Bristol-Myers with $6.1 billion for ImClone
04 October 2008
Ely Lilly, Deciphera tie up for cancer drug research
03 October 2008
Monsanto sells milk-hormone business to Eli Lilly for $300 million
21 August 2008
American drugmaker Eli Lilly buys biotech company SGX Pharma for $64 million
09 July 2008
US FDA delays approval on new drug by Eli Lilly and Daiichi Sankyo
25 June 2008
Suven Life signs another drug research pact with Eli Lilly
12 March 2008
Nicholas Piramal R&D arm in $110-million new drug deal with Eli Lilly
15 February 2008
Eli Lilly predicts higher 2008 profit; to launch new products by 2011
07 December 2007
Eli Lilly launches new diabetic drug
04 October 2007
Eli Lilly accused of concealing health risks of Zyprexa
19 December 2006
Eli Lilly launches anti-diabetes drug variant
11 August 2005
On the clinical trial trail
11 March 2005
Leading firms, Specialty Ranbaxy tie up
01 December 2001
Nicholas Piramal buys four Eli Lilly brands
22 July 1999
Anti-cancer push for Eli Lilly osteoporisis drug
17 June 1999
search domain-b
go
Legal Policy | Copyright
©
1999-2008 The Information Company Private Limited. All rights reserved.
